Universe Pharmaceuticals INC
UPC
$4.91
-$0.21-4.10%
NASDAQ
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 174.57% | 174.57% | -1,731.34% | -1,731.34% | 43.97% |
| Total Depreciation and Amortization | -5.66% | -5.66% | -3.49% | -3.49% | 3.80% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -3,969.07% | -3,969.07% | 3,534.19% | 3,534.19% | -73.77% |
| Change in Net Operating Assets | -184.23% | -184.23% | -113.21% | -113.21% | -6.50% |
| Cash from Operations | -92.21% | -92.21% | -150.63% | -150.63% | 50.45% |
| Capital Expenditure | -308.72% | -308.72% | -11,166.67% | -11,166.67% | -14.74% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -573.39% | -573.39% | -11,166.67% | -11,166.67% | 98.87% |
| Total Debt Issued | 199.94% | 199.94% | 122.39% | 122.39% | -61.43% |
| Total Debt Repaid | 24.90% | 24.90% | 3.19% | 3.19% | -97.32% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 903.28% | 903.28% | 191.58% | 191.58% | -204.00% |
| Foreign Exchange rate Adjustments | 125.46% | 125.46% | -98.41% | -98.41% | 18.47% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 369.08% | 369.08% | -50.62% | -50.62% | 10.04% |